Skip to main content
. 2015 Mar 25;9:17. doi: 10.1186/s12918-015-0158-y

Figure 8.

Figure 8

Growth defects following Sln1 overexpression are not completely due to HOG pathway activation. A We assayed growth in wild-type and ssk1 Δ strains overexpressing Sln1 in response to β-estradiol or carrying an empty P GAL1 vector control. Deletion of Ssk1, which prevented HOG pathway activation by Sln1, partially alleviated the growth defect due to Sln1 overexpression. B Growth of cells on plates containing 10 μM β-estradiol indicated that ssk1 Δ reduced the toxicity of Sln1 overexpression.